Relationship between the development of precore and core promoter mutations and hepatitis B e antigen seroconversion in patients with chronic hepatitis B virus.

Chinese patients with chronic hepatitis B virus (332 with and 44 without cirrhosis-related complications) were studied. Fifty percent of patients <30 years old had precore mutations. The prevalence of precore mutations among hepatitis B e antigen (HBeAg)-positive patients, although lower than that among anti-HBe-positive patients (P=.031), was already high (44.2%). Median HBV DNA level in anti-HBe-positive patients was 1.5 x 10(6)-1.55 x 10(6) copies/mL, irrespective of the presence or absence of precore mutations. There was no difference in the prevalence of precore mutations between patients with and without complications (P, not significant). However the prevalence of core promoter mutations was higher among patients with complications than among those without complications (90.5% vs. 69.3%, respectively; P=.003). In conclusion, precore mutations occurred in a large proportion of Chinese patients with chronic hepatitis B virus before HBeAg seroconversion. The development of complications was not related to precore mutations but was probably due to the persistence of significant viremia after HBeAg seroconversion.

[1]  E. Puchhammer-Stöckl,et al.  Comparison of Sequence Analysis and the INNO-LiPA HBV DR Line Probe Assay for Detection of Lamivudine-Resistant Hepatitis B Virus Strains in Patients under Various Clinical Conditions , 2001, Journal of Clinical Microbiology.

[2]  E. Boxall,et al.  Epidemiology of precore mutants of hepatitis B in the United Kingdom , 2000, Journal of Medical Virology.

[3]  Ding‐Shinn Chen,et al.  Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. , 2000, Gastroenterology.

[4]  L. Stuyver,et al.  Three cases of severe subfulminant hepatitis in heart‐transplanted patients after nosocomial transmission of a mutant hepatitis B virus , 1999, Hepatology.

[5]  C. Hannoun,et al.  Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers. , 1999, The Journal of infectious diseases.

[6]  M. Baptista,et al.  High prevalence of 1762T 1764A mutations in the basic core promoter of hepatitis B virus isolated from black africans with hepatocellular carcinoma compared with asymptomatic carriers , 1999, Hepatology.

[7]  S. Günther,et al.  Naturally occurring variants of hepatitis B virus. , 1999, Advances in virus research.

[8]  J. Nong,et al.  HBV core promoter mutations prevail in patients with hepatocellular carcinoma from Guangxi, China , 1998, Journal of medical virology.

[9]  J. Ou,et al.  Effects of a frequent double-nucleotide basal core promoter mutation and its putative single-nucleotide precursor mutations on hepatitis B virus gene expression and replication. , 1997, The Journal of general virology.

[10]  K. Moriyama,et al.  Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections. , 1996, Virology.

[11]  A. Dhillon,et al.  Hepatitis B virus carriers without precore mutations in hepatitis B e antigen‐negative stage show more severe liver damage , 1996, Hepatology.

[12]  N. Enomoto,et al.  Mutations in the core promoter region of hepatitis B virus in patients with chronic hepatitis B , 1996, Journal of medical virology.

[13]  U. Akarca,et al.  Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[14]  H. Will,et al.  Precore mutant hepatitis B virus infection and liver disease. , 1992, Gastroenterology.

[15]  O. Yokosuka,et al.  Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. , 1991, The New England journal of medicine.